Goldman Sachs’s Poseida Therapeutics, Inc. Common Stock PSTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
|
|||||
|
2024
Q4 | $3.09M | Sell |
|
|||||
|
2024
Q3 | $1.74M | Buy |
|
|||||
|
2024
Q2 | $1.47M | Buy |
|
|||||
|
2024
Q1 | $1.44M | Sell |
|
|||||
|
2023
Q4 | $1.58M | Buy |
|
|||||
|
2023
Q3 | $1.11M | Buy |
|
|||||
|
2023
Q2 | $439K | Sell |
|
|||||
|
2023
Q1 | $904K | Buy |
|
|||||
|
2022
Q4 | $682K | Buy |
|
|||||
|
2022
Q3 | $262K | Buy |
|
|||||
|
2022
Q2 | $116K | Sell |
|
|||||
|
2022
Q1 | $253K | Sell |
|
|||||
|
2021
Q4 | $531K | Buy |
|
|||||
|
2021
Q3 | $416K | Buy |
|
|||||
|
2021
Q2 | $345K | Sell |
|
|||||
|
2021
Q1 | $375K | Sell |
|
|||||
|
2020
Q4 | $461K | Buy |
|
|||||
|
2020
Q3 | $322K | Buy |
|